Since diabetes is a systemic disease impacting numerous metabolic pathways, including mTOR signaling, we hypothesized that targeting the 5-HT6-mTOR pathway may have considerable effects on painful diabetic neuropathy. This evidence concerns the gene MTOR and diabetes mellitus.